Morgan Stanley Spero Therapeutics, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 6,971 shares of SPRO stock, worth $8,225. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,971

Previous 6,971 -0.0%

Holding current value

$8,225

Previous $9,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Oct 17, 2024	SELL	$1.27 - $1.8 $1,178 - $1,670	-928 Reduced 11.75%	6,971 $9,000
Q2 2024 Aug 14, 2024	SELL	$1.27 - $1.8 $1,178 - $1,670	-928 Reduced 11.75%	6,971 $9,000
Q1 2024 Oct 17, 2024	BUY	$1.35 - $1.79 $1,252 - $1,661	928 Added 13.31%	7,899 $13,000
Q1 2024 Aug 16, 2024	SELL	$1.35 - $1.79 $5,583 - $7,403	-4,136 Reduced 34.37%	7,899 $13,000
Q1 2024 May 15, 2024	SELL	$1.35 - $1.79 $5,583 - $7,403	-4,136 Reduced 34.37%	7,899 $13,000
Q4 2023 Aug 16, 2024	BUY	$1.0 - $1.47 $5,064 - $7,444	5,064 Added 72.64%	12,035 $17,000
Q4 2023 Feb 13, 2024	BUY	$1.0 - $1.47 $3,047 - $4,479	3,047 Added 33.9%	12,035 $17,000
Q3 2023 Nov 15, 2023	SELL	$1.2 - $1.63 $650 - $883	-542 Reduced 5.69%	8,988 $10,000
Q2 2023 Aug 14, 2023	SELL	$1.42 - $1.95 $8,094 - $11,115	-5,700 Reduced 37.43%	9,530 $13,000
Q1 2023 May 15, 2023	SELL	$1.35 - $2.0 $2,493 - $3,694	-1,847 Reduced 10.82%	15,230 $22,000
Q4 2022 Feb 14, 2023	SELL	$1.55 - $2.12 $3,374 - $4,615	-2,177 Reduced 11.31%	17,077 $29,000
Q3 2022 Nov 14, 2022	SELL	$0.68 - $2.2 $119,120 - $385,389	-175,177 Reduced 90.1%	19,254 $38,000
Q2 2022 Oct 27, 2022	BUY	$0.74 - $7.44 $89,861 - $903,476	121,435 Added 166.36%	194,431 $144,000
Q2 2022 Aug 15, 2022	BUY	$0.74 - $7.44 $89,861 - $903,476	121,435 Added 166.36%	194,431 $144,000
Q1 2022 Oct 27, 2022	SELL	$7.87 - $15.15 $955,693 - $1.84 Million	-121,435 Reduced 62.46%	72,996 $635,000
Q1 2022 May 13, 2022	BUY	$7.87 - $15.15 $177,161 - $341,041	22,511 Added 44.59%	72,996 $635,000
Q4 2021 Feb 14, 2022	SELL	$13.09 - $18.77 $78,749 - $112,920	-6,016 Reduced 10.65%	50,485 $808,000
Q3 2021 Nov 15, 2021	BUY	$13.03 - $19.51 $736,208 - $1.1 Million	56,501 New	56,501 $1.04 Million

Others Institutions Holding SPRO

# of Institutions

Shares Held

13.9M

Call Options Held

200

Put Options Held

200

View Full List

About Spero Therapeutics, Inc.

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $41.4M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

More about SPRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account